Skip to product information
1 of 1

CD8 Nanobeads, human(RUO)

CD8 Nanobeads, human(RUO)

Catalog Number: S0K0010 Reactivity: Human Conjugation: Brand: Starter
Price:
Regular price $300 USD
Regular price Sale price $300 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Format

Dextran-coated iron tetroxide nanomagnetic beads coupled with an anti-human CD8 monoclonal antibody

Capacity

2 mL magnetic beads: suitable for a total cell count of 1×10⁹, and can perform up to 100 separations

1 mL magnetic beads: suitable for 5×108total cells, and can perform up to 50 separations

Principle of Separation

CD8⁺ cells are magnetically labeled using CD8 Nanobeads for humans. The cell suspension is then loaded into a separation column placed within the sorter's magnetic field. The magnetically labeled CD8⁺ cells remain retained in the column, while the unlabeled cells elute; this fraction constitutes the negative fraction after removal of CD8⁺ cells. After removing the separation column from the magnetic field, the magnetically captured CD8⁺ cells can be eluted, yielding the positive sorted fraction. If higher purity is required, the positive sorted fraction containing CD8⁺ cells must be further separated using a second column.

Reactivity Human
Magnetic Bead Size 20 nm
Separation Method Column-Based
Selection Strategy Positive Selection
Stability & Storage

Store protected from light at 2–8°C; do not freeze.

Background

CD8 antigen forms a complex with the T-cell receptor and serves as a co-molecule on CD8+ cytotoxic T cells, assisting the TCR heterodimer in recognizing MHC class I–peptide complexes. The CD8 molecule consists of an α/β heterodimer or an α/α homodimer. It is highly expressed on cytotoxic T cells and weakly expressed on some NK cells. CD8 is present on most thymocytes and approximately one-third of peripheral blood T cells. CD8+ cytotoxic T cells play a crucial role in eliminating virus-infected cells and tumor cells.

Protocol

Note: This kit does not include the sorting buffer; it must be provided separately. The corresponding Stater catalog number isS0D3018

Taking S as an exampleSeparation Columnfor instance

Steps

Operating procedures

Dosage / Time

Magnetic labeling

1

Count the total number of cells

—

2

Centrifuge the cell suspension at 400×g for 7 minutes, and completely discard the supernatant

400×g, 7 min

3

Resuspend every 1×10⁷ cells in 80 μL of buffer

Note:Adjust the volume of the buffer proportionally according to the sample volume

Resuspend the cells

4

Add 20 μL of CD8 NanoBeads per 1×10⁷ cells

Note:When the number of cells increases, increase the volumes of all reagents proportionally

Add 20 μL per 1×10⁷ cells

5

Mix thoroughly and incubate in the dark at 2–8℃ for 15 minutes

Incubate for 15 minutes

6

Wash every 1×10⁷ cells with 1 mL of buffer, centrifuge at 400×g for 7 minutes, and completely discard the supernatant.

Add 1 mL to 1×10⁷ cells

7

Resuspend up to 1×10⁸ cells in 500 μL of buffer8Cells

Resuspend cells

Magnetic separation

8

Place the S-type separation column into the magnetic field of the corresponding magnetic separator, and rinse the column with 500 μL of buffer.

Rinse the separation column

9

Load the cell suspension onto the separation column and collect the flow-through (unlabeled cells).

—

10

Wash the column three times with 500 μL of buffer each time, adding the next wash only after the liquid inside the column has completely drained.

3 × 500 μL of buffer

11

Combine all flow-through fractions into the negative fraction; remove the separation column from the magnetic field and place it over the collection tube.

—

12

Add 1 mL of buffer to the column, and quickly and firmly push the accompanying plunger to elute the magnetically labeled positive cells.

Note:For higher purity, use a new column and repeat the separation once.

Collect the target cells.


With LSeparation Columnas an example

Steps

Operating method

Dosage / Time

Magnetic labeling

1

Count the total number of cells

—

2

Centrifuge the cell suspension at 400×g for 7 minutes, and completely discard the supernatant.

400×g, 7 min

3

Resuspend every 1×10⁷ cells in 80 μL of buffer.

Note:Adjust the volume of the buffer proportionally according to the sample volume.

Resuspend the cells.

4

Add 20 μL of CD8 NanoBeads per 1×10⁷ cells.

Note:When the cell quantity increases, increase the volume of all reagents proportionally at the same time.

Add 20 μL per 1×10⁷ cells.

5

Mix thoroughly and incubate in the dark at 2–8℃ for 15 minutes.

Incubate for 15 min.

6

Wash every 1×10⁷ cells with 1 mL of buffer, centrifuge at 400×g for 7 minutes, and completely discard the supernatant.

Add 1 mL to 1×10⁷ cells

7

Resuspend up to 1×10 in 500 μL of buffer8Cells

Resuspend cells

Magnetic separation

8

Place the L-shaped separation column into the magnetic field of the corresponding magnetic separator, and rinse the column with 3 mL of buffer.

Rinse the separation column

9

Load the cell suspension onto the separation column and collect the effluent (unlabeled cells).

—

10

Wash the column with buffer three times, each time using 3 mL; add the next wash only after the liquid inside the column has completely drained.

3 × 3 mL of buffer

11

Combine all effluents into the negative fraction; remove the separation column from the magnetic field and place it over the collection tube.

—

12

Add 5 mL of buffer to the column, and quickly and firmly push the accompanying plunger to elute the magnetically labeled positive cells.

Note:For higher purity, use a new column and repeat the separation once.

Collect the target cells.


Picture

Validation Data

CD8+ T cells are enriched or depleted from human PBMCs using CD8 Nanobeads, S or L Separation Columns, and a magnetic separator. Subsequently, fluorescent staining is performed with anti-CD8 (clone: OKT8) Alexa Fluor® 488, and the live cell population is gated for analysis.